Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway.

Saved in:
Bibliographic Details
Title: Knockdown of subunit 3 of the COP9 signalosome inhibits C2C12 myoblast differentiation via NF-KappaB signaling pathway.
Authors: Ba MA; Department of Pharmacology, University of Nevada School of Medicine, Reno, NV, USA. mba@unr.edu., Surina J; Department of Pharmacology, University of Nevada School of Medicine, Reno, NV, USA., Singer CA; Department of Pharmacology, University of Nevada School of Medicine, Reno, NV, USA., Valencik ML; Department of Pharmacology, University of Nevada School of Medicine, Reno, NV, USA.
Source: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2017 Jun 17; Vol. 18 (1), pp. 47. Date of Electronic Publication: 2017 Jun 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101590449 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-6511 (Electronic) Linking ISSN: 20506511 NLM ISO Abbreviation: BMC Pharmacol Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-6511
DOI:10.1186/s40360-017-0154-5